COMMUNIQUÉS West-GlobeNewswire

Orion Group Interim report January–September 2026: Strong financial performance and positive developments in the R&D pipeline
28/10/2026
ORION CORPORATION INTERIM REPORT 1–9/2026 28 OCTOBER 2026 at 12:00 EET Orion Group Interim report January–September 2026: Strong financial performance and positive developments in the R&D pipeline July–September [...]
Rapport Announces Pricing of Underwritten Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes and Concurrent Private Placement
28/10/2026
BOSTON and SAN DIEGO, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small [...]
Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program
28/10/2026
EMphora™ platform integrates clinical evidence and predictive modelling to help identify promising cancer patient populations and guide the next phase of research VANCOUVER, British Columbia, Oct. 28, 2026 (GLOBE [...]
Nxera Pharma Secures Exclusive Rights to Fabry Disease Phase 3 Oral Therapy Candidate Lucerastat for Japan and Selected Asia Pacific Markets
28/10/2026
Nxera has exercised its option to license lucerastat for Japan, South Korea, Taiwan and selected other Asia Pacific markets (excluding China), paying Idorsia CHF 7 million upfront and contributing to the global Phase 3 [...]
Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma
28/10/2026
The VENTANA BAP1 (SP527) test helps confidently distinguish malignant mesothelioma from lung, breast and stomach cancers, as well as benign tissue growth in the chest or abdomen. Most patients are diagnosed with [...]
Idorsia initiates pivotal Phase 3 study for lucerastat in Fabry disease and enters co-development and commercialization agreement with Nxera
28/10/2026
FAB-KLEAR investigates lucerastat as a potential disease-modifying therapy targeting the kidney manifestations of Fabry disease. Nxera will contribute to development and hold commercialization rights in Japan and [...]
Junshi Biosciences Announces Final Analysis Results of the Phase 3 NEOTORCH Study at ESMO Congress 2026
28/10/2026
Perioperative toripalimab plus chemotherapy demonstrated significant and durable improvements in event-free survival and overall survival in patients with resectable stage II-III non-small cell lung cancer. SHANGHAI, [...]
15-year-old Designs Low-Cost Device to Monitor Airborne Bacteria in the Environment; Wins $25,000 Top Award at the 2026 Thermo Fisher Scientific Junior Innovators Challenge
28/10/2026
Young innovators awarded more than $100,000 for research on dementia-related proteins, alternatives to agricultural plastics and wildfire prevention Key Takeaways: Thermo Fisher Scientific and Society for Science [...]
Newsweek Places KFSH in Top 4% of World's Smart Hospitals for Digital Maturity and AI
28/10/2026
RIYADH, Saudi Arabia, Oct. 27, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) is one of only 15 hospitals worldwide to receive both the maximum five-ribbon digital maturity rating [...]
Latest Data of Orelabrutinib Presented at the European Society for Medical Oncology (ESMO) Congress 2026
28/10/2026
BEIJING, Oct. 27, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that latest data of [...]
UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026
27/10/2026
Conference Call and Webcast Scheduled for Wednesday, November 4th, 2026, at 10:00 AM ET PRINCETON, N.J., Oct. 27, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and [...]
INVO Fertility Announces a 1:4 Reverse Stock Split Effective Pre-Market Opening on October 30, 2026
27/10/2026
SARASOTA, Fla., Oct. 27, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the establishment, acquisition and operation of fertility clinics and related businesses and [...]
Ossium Health CEO Kevin Caldwell Wins 2026 Biocom Catalyst Award
27/10/2026
SAN FRANCISCO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Kevin Caldwell, Ossium Health CEO, Co-Founder & President, has been named a winner of the 2026 Biocom Catalyst Award. Now in its 11th year, the Catalyst Awards honor [...]
Northwestern Medicine establishes a Transplant Institute focused on innovation and access
27/10/2026
The Northwestern Medicine Transplant Institute launches on the heels of surgeons performing Northwestern Medicine’s 3,000th liver transplant B-roll, photos and interview: https://www.dropbox.com/scl/fo/ [...]
Rapport Announces Proposed Public Offerings of Common Stock and Convertible Notes as well as Concurrent Private Placement
27/10/2026
BOSTON and SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small [...]
Carlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026
27/10/2026
CARLSBAD, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced [...]
DBV Technologies to Report Third Quarter 2026 Financial Results and Business Update on October 28, 2026
27/10/2026
Châtillon, France, October 27, 2026 DBV Technologies to Report Third Quarter 2026 Financial Results and Business Update on October 28, 2026 Company to host investor conference call and webcast at 5:00pm ET DBV [...]
DBV Technologies présente ses résultats financiers du troisième trimestre 2026 et fait le point sur ses activités
27/10/2026
Châtillon, France, le 27 octobre (22 :30 CEST) 2026 DBV Technologies présente ses résultats financiers du troisième trimestre 2026 et fait le point sur ses activités DBV La Société organise une conférence téléphonique [...]
CooperCompanies Announces Leadership Transition and Board Refreshment
27/10/2026
Independent Director and Seasoned Healthcare Executive Walt Rosebrough Elected Executive Chair; Search for CEO Underway Provides Update on Board Refreshment, Including Planned Addition of Medical Device and Vision [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum